Enhancement of Skin Permeation and Skin Immunization of Ovalbumin Antigen via Microneedles.
The purpose of this study was to evaluate the use of different types of microneedles and doses of ovalbumin antigen for in vitro skin permeation and in vivo immunization. In vitro skin permeation experiments and confocal laser scanning microscopy revealed that hollow microneedles had a superior enhancing effect on skin permeation compared with a solid microneedle patch and untreated skin by efficiently delivering ovalbumin-fluorescein conjugate into the deep skin layers. The flux and cumulative amount of ovalbumin-fluorescein conjugate at 8 h after administering with various conditions could be ranked as follows: hollow MN; high dose > medium dose > low dose > MN patch; high dose > medium dose > low dose > untreated skin; high dose > medium dose > low dose > without ovalbumin-fluorescein conjugate. As the dose of ovalbumin-fluorescein conjugate was increased to 500 μg, the antigen accumulated in the skin to a greater extent, as evidenced by the increasing green fluorescence intensity. When the hollow microneedle was used for the delivery of ovalbumin into the skin of mice, it was capable of inducing a stronger immunoglobulin G immune response than conventional subcutaneous injection at the same antigen dose. Immunoglobulin G levels in the hollow MN group were 5.7, 11.6, and 13.3 times higher than those of the subcutaneous injection group for low, medium, and high doses, respectively. Furthermore, the mice immunized using the hollow microneedle showed no signs of skin infection or pinpoint bleeding. The results suggest that the hollow MN is an efficient device for delivering the optimal dose of antigen via the skin for successful immunization.
Faculty of Pharmacy, Pharmaceutical Development of Green Innovations Group (PDGIG), Silpakorn University, Nakhon Pathom, 73000, Thailand.
Boonnada
B
Pamornpathomkul
Faculty of Pharmacy, Pharmaceutical Development of Green Innovations Group (PDGIG), Silpakorn University, Nakhon Pathom, 73000, Thailand.
Theerasak
T
Rojanarata
Faculty of Pharmacy, Pharmaceutical Development of Green Innovations Group (PDGIG), Silpakorn University, Nakhon Pathom, 73000, Thailand.
Praneet
P
Opanasopit
Faculty of Pharmacy, Pharmaceutical Development of Green Innovations Group (PDGIG), Silpakorn University, Nakhon Pathom, 73000, Thailand. ngawhirunpat_t@su.ac.th.
Tanasait
T
Ngawhirunpat
D000279:Administration, Cutaneous; D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology; D007114:Immunization; D007074:Immunoglobulin G / Q000096:biosynthesis; D051379:Mice; D009339:Needles; D010047:Ovalbumin / Q000008:administration & dosage* / Q000276:immunology / Q000493:pharmacokinetics; D012867:Skin / Q000378:metabolism*
D000941:Antigens; D007074:Immunoglobulin G; C042851:fluorescein-ovalbumin; D010047:Ovalbumin
hollow microneedle; ovalbumin; skin immunization; solid microneedle